Therapeutic Vaccines for Cancer Treatment
VPM organizes clinical development - Initial focus on prostate cancer
21-Apr-2004 -
Braunschweig/Munich/New York. Vakzine Projekt Management GmbH (VPM),
Braunschweig, Germany, has obtained from Memorial Sloan-Kettering Cancer
Center a worldwide exclusive license for several patents covering a
range of recombinant cell lines. These cell lines have a high potential
to ...
cancer therapy
cell lines
chemotherapy
+16